Winston-Salem 4/28/2010 6:41:07 PM
News / Business

SmallCapReview - Small Cap Stocks to Watch - FLPC, BCRX, DSCO

SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999, to receive the free SmallCapReview newsletter visit http://www.smallcapreview.com/.

First Liberty Power Corp (OTCBB: FLPC) $0.74. Announced last week the results from a radon survey conducted on the Company's 66 mineral lode claims, located in San Juan County, Utah (the "Uravan mineral claims").

Glyn R. Garner, President and CEO of First Liberty Power Corp., commented, "We are very encouraged by the results of this initial radon survey. Historical data shows ore produced at the nearby Firefly mine through 1956 contained over 2% Vanadium. The data from this survey indicates an anomalous east-west radiometric trend and the size of the anomalies appears to be similar to the size of the high grade vanadium-uranium beds mined from the Firefly , Gray Daun and Vanadium Queen Mine."

Garner added, "The Subaru G4e concept car that utilizes a high-density vanadium-assisted lithium battery technology and the vanadium redox flow battery being developed by companies like Cellstrom, show that a mixed approach is the best exploration and acquisition strategy for a company like First Liberty, unlike so many companies in the sector that are focusing just on lithium, we are building a diversified portfolio of projects. I believe the clean energy revolution is underway and it will be powered by vanadium and lithium."

The Uravan mineral claims radon survey consisted of 101 readings with a minimum reading of 0.35 and a maximum reading of 27.75. The median reading was 6.75 with a midrange of 14.05. The preliminary radon survey data indicates an anomalous east-west radiometric trend. A detailed radon survey would further define drill targets and thereby delineate tonnage and grade within the Uravan Claim Block.

The radon survey uses a system that measures the radon by utilizing an ion chamber with an electrically charged Teflon, called an electret, located inside an electrically conducting plastic chamber of known air volume. The electrets serve as a source of high voltage needed for the chamber to operate as an ion chamber. It also serves as a sensor for the measurement of ionization in air. The ions produced inside the sensitive volume of the chamber are collected by the electrets causing a depletion of charge. The measurement of the depleted charge during the exposure period is a measure of integrated ionization during the measurement period. The electrets charge is read before and after the exposure using a specially built non-contact electret voltage reader.

What They Do: First Liberty Power Corp. is a Nevada based mineral exploration company with a primary focus on lithium and vanadium exploration and development in the United States. The Company is positioned to capitalize on the anticipated increase in demand for both lithium carbonate and vanadium that is projected to result from the adoption and use of clean renewable energy that will fuel demand for products that utilize lithium-ion batteries and vanadium redox batteries.

BioCryst Pharmaceuticals (Nasdaq: BCRX). Today announced positive top-line results from a planned interim analysis of its ongoing Phase 2a, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of orally administered BCX4208 in patients with gout.

The study’s primary endpoint is the change in serum uric acid concentration after 21 days of treatment compared to baseline concentration prior to treatment. Part one of the study randomized 60 gout patients with serum uric acid concentrations greater than or equal to 8 mg/dL to placebo or to one of three different doses of BCX4208, a purine nucleoside phosphorylase (PNP) inhibitor, administered once-daily for 21 days. All three doses of BCX4208 demonstrated a statistically significant reduction in serum uric acid levels compared to placebo at day 22. BCX4208 doses of 40 mg, 80 mg and 120 mg per day showed median reductions in serum uric acid levels of 2.7, 3.3 and 3.4 mg/dL, respectively.

What They Do: BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases.

Discovery Laboratories (Nasdaq: DSCO) $0.52. Today announced that new data supporting the unique properties of its KL4 surfactant technology will be presented at the upcoming Pediatric Academic Societies Annual Meeting (May 1 -- 4, 2010) and at the American Thoracic Society International Conference (May 14 -- 19, 2010). The Pediatric Academic Societies Annual Meeting is internationally recognized as the most relevant medical meeting dedicated to pediatric research. The American Thoracic Society International Conference is internationally recognized as the largest and most important medical congress featuring the latest information on clinical, basic, and translational science in pulmonary, critical care and sleep medicine. 

What They Do: Discovery Laboratories, Inc. is a biotechnology company developing surfactant therapies for respiratory diseases.


About SmallCapReview

Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit http://www.smallcapreview.com/. To follow us on Twitter visit http://twitter.com/SmallCapReview.

The profile and opinions expressed herein are expressed as of the date the profile is posted on site and are subject to change without notice. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. SmallCapReview may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports  In order to be in full compliance with the Securities Act of 1933, Section 17(b), SCR will disclose in it's disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on the SmallCapReview website. SmallCapReview has been compensated five thousand dollars for its efforts with regards to First Liberty Power by a third party AWT.